Article Details

Amgen study data bolster prospects of KRAS-blocking cancer drug

Retrieved on: 2021-01-28 21:56:15

Tags for this article:

Click the tags to see associated articles and topics

Amgen study data bolster prospects of KRAS-blocking cancer drug. View article details on hiswai:

Excerpt

BioPharma Dive Amgen's KRAS drug can shrink tumors for months, but new data leave room for improvement offsite link. Follow Ned Pagliarulo on ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo